PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 1, 1996Antimicrobial Agents and Chemotherapy78 citationsOpen Access

Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones

JGJohn GoldmanDWDavid G. WhiteSLStuart B. Levy

Key Points

  • To investigate the role of the multiple antibiotic resistance (mar) locus and its operons in protecting Escherichia coli against the rapid bactericidal action of fluoroquinolones.
  • Evaluated the bactericidal susceptibility of E. coli strains harboring overexpressed, inactivated, or deleted marRAB and marC operons against fluoroquinolones.
  • Assessed rapid cell killing across varying concentrations of fluoroquinolones and compared responses with hipA and hipQ phenotypes.
  • Overexpression of the marRAB operon protected E. coli from rapid fluoroquinolone-mediated killing, whereas operon inactivation restored wild-type bactericidal susceptibility.
  • Both marC and marRAB operons were required to confer protection against quinolone-mediated bactericidal activity in mar deletion mutants.
  • The protective antibactericidal effect was lost at high fluoroquinolone concentrations, differentiating this mechanism from hipA- and hipQ-mediated survival.

Abstract

The multiple antibiotic resistance (mar) locus in Escherichia coli consists of two divergently expressed operons (marC and marRAB), both of which contribute to the Mar phenotype. Overexpression of the marRAB operon protected E. coli against rapid cell killing by fluoroquinolones. Inactivation of the operon in mar mutants restored a wild-type bactericidal susceptibility. Both operons of the locus were required for protection from the quinolone-mediated bactericidal activity in mar locus deletion mutants. The effect was lost at high concentrations of fluoroquinolones, unlike the case for the previously described genes hipA and hipQ. The inducible mar locus appears to specify a novel antibactericidal mechanism which may play a role in the emergence of fluoroquinolone-resistant clinical E. coli isolates.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Goldman et al. (1996) studied this question.

synapsesocial.com/papers/6a70746935aa2c282ce1c6edhttps://doi.org/10.1128/aac.40.5.1266
Ask AI
Helpful
Bookmark
Share
View Full Paper